RCM Technologies, Inc.: Form 10-Q for the period ended Sep 27, 2025
Filed with the SEC on Nov 6, 2025 and accepted by EDGAR at Nov 6, 2025, 16:19 ET.
Management's discussion and analysis
As filed, 4,473 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Private Securities Litigation Reform Act Safe Harbor Statement
Certain statements included herein and in other reports and public filings made by RCM Technologies, Inc. (“RCM” or the “Company”) are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, without limitation, statements regarding the adoption by businesses of new technology solutions; the use by businesses of outsourced solutions, such as those offered by the Company, in connection with such adoption; the Company’s strategic and business initiatives and growth strategies; and the outcome of litigation (at both the trial and appellate levels) and arbitrations, or other business disputes, involving the Company. Readers are cautioned that such forward-looking statements, as well as others made by the Company, which may be identified by words such as “may,” “will,” “expect,” “anticipate,” “continue,” “estimate,” “project,” “intend,” “believe,” and similar expressions, are only predictions and are subject to risks and uncertainties that could cause the Company’s actual results and financial position to differ materially from such statements. Such risks and uncertainties include, without limitation: (i) unemployment and general economic conditions affecting the provision of life sciences, information technology and engineering services and solutions and the placement of temporary staffing personnel; (ii) the Company’s ability to continue to attract, train and retain personnel qualified to meet the requirements of its clients; (iii) the Company’s ability to identify appropriate acquisition candidates, complete such acquisitions and successfully integrate acquired businesses; (iv) the Company’s relationships with and reliance upon significant customers, and ability to collect accounts receivable from such customers; (v) risks associated with foreign currency fluctuations and changes in exchange rates, particularly with respect to the Canadian dollar; (vi) uncertainties regarding amounts of deferred consideration and earnout payments to become payable to former shareholders of acquired businesses; (vii) the adverse effect a potential decrease in the trading price of the Company’s common stock would have upon the Company’s ability to acquire businesses through the issuance of its securities; (viii) the Company’s ability to obtain financing on satisfactory terms; (ix) the reliance of the Company upon the continued service of its executive officers; (x) the Company’s ability to remain competitive in the markets that it serves; (xi) the Company’s ability to maintain its unemployment insurance premiums and workers compensation premiums; (xii) the risk of claims being made against the Company associated with providing temporary staffing services; (xiii) the Company’s ability to manage significant amounts of information and periodically expand and upgrade its information processing capabilities; (xiv) the risk of cyber attacks on our information technology systems or those of our third party vendors; (xv) the Company’s ability to remain in compliance with federal and state wage and hour laws and regulations; (xvi) uncertainties in predictions as to the future need for the Company’s services; (xvii) uncertainties relating to the allocation of costs and expenses to each of the Company’s operating segments; (xviii) the costs of conducting and the outcome of litigation, arbitrations and other business disputes involving the Company, and the applicability of insurance coverage with respect to any such litigation; (ixx) the results of, and costs relating to, any interactions with shareholders of the Company who may pursue specific initiatives with respect to the Company’s governance and strategic direction, including without limitation a contested proxy solicitation initiated by such shareholders, or any similar such interactions; and (xx) other geopolitical, economic, competitive, health and governmental factors affecting the Company’s operations, markets, products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, the Company undertakes no obligation to publicly release the results of any revision of these forward-looking statements to reflect these trends or circumstances after the date they are made or to reflect the occurrence of unanticipated events.
Market risk
As filed, 1,185 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The Company’s exposure to market risk for changes in interest rates relates primarily to the Company’s investment portfolio and debt instruments, which primarily consist of the Revolving Credit Facility. The Company does not have any derivative financial instruments in its portfolio. The Company places its investments in instruments that meet high credit quality standards. The Company is adverse to principal loss and ensures the safety and preservation of its invested funds by limiting default risk, market risk and reinvestment risk. As of September 27, 2025, the Company’s investments consisted of cash and money market funds. The Company does not use interest rate derivative instruments to manage its exposure to interest rate changes. Based on the Company’s variable-rate line of credit balances during the thirty-nine weeks ended September 27, 2025, if the interest rate on the Company’s variable-rate line of credit (using an incremental borrowing rate) during the period had been 1.0% higher, the Company’s interest expense on an annualized basis would have increased by $0.3 million. The Company does not expect any material loss with respect to its investment portfolio.
Controls and procedures
As filed, 1,662 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The Company maintains disclosure controls and procedures (as defined in Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) that are designed to ensure that information required to be disclosed in Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
Evaluation of Disclosure Controls and Procedures
As of September 27, 2025, the Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures. Based on the foregoing, the Company’s Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective as of the end of the period covered by this report.
Changes in Internal Control over Financial Reporting
There were no changes during the fiscal quarter ended September 27, 2025, in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.
RCM TECHNOLOGIES, INC. AND SUBSIDIARIES PART II - OTHER INFORMATION
Risk factors
As filed, 232 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
For information regarding factors that could affect the Company’s business, see the risk factors discussed under Part I, Item 1A, Risk Factors, of the Company’s Annual Report on Form 10-K for the fiscal year ended December 28, 2024.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-09-27. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-06-29 to 2025-09-27 | $70.3m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Revenue | 9 months2024-12-29 to 2025-09-27 | $232.9m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 3 months2025-06-29 to 2025-09-27 | $50.9m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2024-12-29 to 2025-09-27 | $169.3m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2025-06-29 to 2025-09-27 | $19.4m | us-gaap:GrossProfit |
| Gross profit | 9 months2024-12-29 to 2025-09-27 | $63.7m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2025-06-29 to 2025-09-27 | $14.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2024-12-29 to 2025-09-27 | $45.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2025-06-29 to 2025-09-27 | $3.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2024-12-29 to 2025-09-27 | $17.1m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2025-06-29 to 2025-09-27 | $1.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2024-12-29 to 2025-09-27 | $4.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-06-29 to 2025-09-27 | $2.3m | us-gaap:NetIncomeLoss |
| Net income | 9 months2024-12-29 to 2025-09-27 | $10.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-06-29 to 2025-09-27 | $0.30 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2024-12-29 to 2025-09-27 | $1.34 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-06-29 to 2025-09-27 | $0.30 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2024-12-29 to 2025-09-27 | $1.37 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-06-29 to 2025-09-27 | 7,614,695 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2024-12-29 to 2025-09-27 | 7,656,929 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2024-12-29 to 2025-09-27 | $7.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2024-12-29 to 2025-09-27 | $1.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2024-12-29 to 2025-09-27 | $5.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2025-09-27 | $1.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-09-27 | $94.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-09-27 | $129.8m | us-gaap:Assets |
| Current liabilities | At period end2025-09-27 | $48.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-09-27 | $88.4m | us-gaap:Liabilities |
| Shareholders' equity | At period end2025-09-27 | $41.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-25-033607. Last ingested by Listed: Oct 24, 2026, 14:56 ET. Listed shows no prices and gives no investment advice.